Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
Conditions
Parkinson's Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Institute for Neurodegenerative Disorders / XingImaging, LLC, New Haven, Connecticut, United States
Contact: Study coordinator (Ashley Romano, Clinical Research Nurse II, RN) · info_XI001@xingimaging.com · 475-318-8232Contact: Study coordinator (Lydia Currie, Clinical Research Manager) · info_XI001@xingimaging.com · 475-318-8250Contact: Principal Investigator (Neha Prakash, MBBS)
Study leads
Ken Marek, MD
Study Chair
Institute for Neurodegenerative Disorders